MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/labmed/lmaa008

Медицинская библиотека · Laboratory medicine · 2020

Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia.

Markin Pavel A, Brito Alex, Moskaleva Natalia, Fodor Miguel, Lartsova Ekaterina V, Shpot Yevgeny V, Lerner Yulia V, Mikhajlov Vasily Y, Potoldykova Natalia V, Enikeev Dimitry V, Lyundup Alexey V, Appolonova Svetlana A

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Sarcosine was postulated in 2009 as a biomarker for prostate cancer (PCa). Here, we assess plasma sarcosine as a biomarker that is complementary to prostate-specific antigen (PSA).

METHODS

Plasma sarcosine was measured using gas chromatography-mass spectrometry (GC-MS) in adults classified as noncancerous controls (with benign prostate hyperplasia [BPH], n = 36), with prostatic intraepithelial neoplasia (PIN, n = 16), or with PCa (n = 27). Diagnostic accuracy was assessed using receiver operating characteristic curve analysis.

RESULTS

Plasma sarcosine levels were higher in the PCa (2.0 µM [1.3-3.3 µM], P <.01) and the PIN (1.9 µM [1.2-6.5 µM], P <.001) groups than in the BPH (0.9 µM [0.6-1.4 µM]) group. Plasma sarcosine had "good" and "very good" discriminative capability to detect PIN (area under the curve [AUC], 0.734) and PCa (AUC, 0.833) versus BPH, respectively. The use of PSA and sarcosine together improved the overall diagnostic accuracy to detect PIN and PCa versus BPH.

CONCLUSION

Plasma sarcosine measured by GC-MS had "good" and "very good" classification performance for distinguishing PIN and PCa, respectively, relative to noncancerous patients diagnosed with BPH.

Для цитирования: Markin Pavel A, Brito Alex, Moskaleva Natalia, Fodor Miguel, Lartsova Ekaterina V, Shpot Yevgeny V, Lerner Yulia V, Mikhajlov Vasily Y, Potoldykova Natalia V, Enikeev Dimitry V, Lyundup Alexey V, Appolonova Svetlana A. Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia.. Laboratory medicine. 2020. DOI: 10.1093/labmed/lmaa008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.